UTHR - United Therapeutics Corporation (UTHR) CEO Martine Rothblatt on Q4 2021 Results - Earnings Call Transcript

United Therapeutics Corporation (UTHR) Q4 2021 Earnings Conference Call February 24, 2022, 09:00 AM ET Company Participants Dewey Steadman - Head of IR Martine Rothblatt - Founder, Chairman and CEO Michael Benkowitz - President and COO Conference Call Participants Joseph Thome - Cowen and Company Eun Yang - Jefferies LLC Jessica Fye - JPMorgan Andreas Argyrides - Wedbush Securities Inc. Presentation Operator Good morning, and welcome to the United Therapeutics Corporation Fourth Quarter and Full Year 2021 Earnings Webcast. My name is Emma, and I will be your conference operator today. All participants on the call portion of this webcast will be in listen-only mode until the question-and-answer portion of this earnings call. [Operator Instructions] I will now turn the webcast over to Dewey Steadman, Head of Investor Relations at United Therapeutics. Dewey Steadman Good morning, and thank you, Emma. It's my pleasure to welcome you to the United Therapeutics

For further details see:

United Therapeutics Corporation (UTHR) CEO Martine Rothblatt on Q4 2021 Results - Earnings Call Transcript